Glucose Health, Inc. Reports
Q1 Fiscal
2021 Revenue
Increases
187%
BENTONVILLE,
AR -- May
17, 2021
-- InvestorsHub NewsWire -- Glucose Health, Inc. (OTC:
"GLUC")
("Company") is pleased to highlight key
financial
information
detailed
in its Fiscal 2021
Quarterly
Report
for
the period ending March 31, 2021, posted
this
morning at OTCMarkets.com.
- Fiscal
2021 Q1 Revenue
of $237,465
vs.
$82,613
for
Q1
2020
–
an
increase
of 187%.
- Fiscal
2021
Gross
Profit of $114,871
vs.
$39,094
for
Q1
2020
–
an
increase of 194%.
- Total
Assets of $1,262,071 ($941,887
cash)
at
March
31, 2021 vs. Total Assets of $341,321 ($69,151
cash)
at
March 31, 2020 –
an
increase of 270%.
- Total
Liabilities of $275,922
at
March
31, 2021 vs.
Total
Liabilities of $303,526
at March 31, 2020
–
a
decrease
of 9%.
- Inventory
of
$264,001
at
March
31, 2021 vs
$124,776
at March 31, 2020 – an
increase of 112%.
Today,
Glucose
Health, Inc. is
also
pleased
to advise
the
"substantial
doubt as to the Company's ability to continue as a going
concern"
assumption
noted in its financial
statements,
has
been
removed.
"Substantial
doubt" assumptions
are present
in
the
financial statements of many
companies
quoted
on
OTC
Markets
and
even
found
in the
financial statements
of
companies
listed
on stock exchanges such as NASDAQ.
The
removal
of
the
"substantial
doubt" assumption
indicates
that
GLUC has
joined
the
ranks of companies
which have achieved
the
measure
of financial
stability
necessary
to
meet their
obligations
and continue in
business for
the foreseeable future.
About Glucose Health, Inc. (OTC:
GLUC)
With
a
focus
on creating delicious beverages
nutritionally appropriate1 for
the nation's 100+ million2 pre
and Type-2 diabetics, Glucose
Health, Inc., the manufacturer of GLUCODOWN®, is
uniquely
positioned
among all
emerging beverage
companies in America. Introduced in the third quarter of
2018,
the
GLUCODOWN®
brand
has
successfully established itself
at the forefront of an
entirely new
nutritional supplement
category
– functional, diabetic friendly, beverages. Glucose
Health, Inc. is a publicly traded company with the ticker symbol
OTC: GLUC.
For
more GLUC news visit www.glucosehealthinc.com
Like us on
Facebook at www.facebook.com/glucodown
1
For
citations visit www.glucodown.com/clinical-data
2
National Diabetes Statistics Review, 2020;
Centers for Disease Control and Prevention, Department of Health
and Human Services
This news release
contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and
while
Glucose
Health, Inc. is not subject to the 1934 Securities and Exchange
Act, contains forward-looking statements within the meaning Section
21E of the Securities and Exchange Act of 1934, as amended.
Statements that are not a description of historical facts
constitute forward-looking statements and may often, but not
always, be identified by the use of such words as "expects,"
"anticipates," "intends," "estimates," "plans," "potential,
"possible," "probable, "believes," "seeks," "may, "will, "should,"
"could" or the negative of such terms or other similar expressions.
Actual results may differ materially from those set forth in this
release due to the risks and uncertainties inherent in the
Company's business. Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date hereof. All forward-looking statements are qualified in
their entirety by this cautionary statement and the Company
undertakes no obligation to revise or update this release to
reflect events or circumstances after the date hereof.
Contact:
Murray
Fleming
Glucose Health,
Inc.
info@glucosehealthinc.com
(479)
802-3827
